A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective studySheri L. Spunt, Douglas S. Hawkins, Lynn Million et al.|The Lancet Oncology|2019Cited by 182
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology GroupEtan Orgel, Mignon L. Loh, Meenakshi Devidas et al.|Blood|2024Cited by 0